#FlagshipFounded Apriori Bio announces funding from CEPI (Coalition for Epidemic Preparedness Innovations) to help advance its Octavia™ platform aimed at protecting humanity against rapidly-evolving viruses by designing variant-resilient vaccines. ⬇
We are pleased to announce that we have been awarded funding from CEPI (Coalition for Epidemic Preparedness Innovations), a global leader in pandemic preparedness, to help advance our biology-informed #artificialintelligence platform Octavia™. The insights we gather from Octavia will help to ensure the global community is better prepared to effectively address future outbreaks with precision and speed. Through this work, we aim to develop variant-resilient vaccines that remain protective for years to come, with an initial focus on further exploring pandemic influenza strain H3N2. Read more about how these funds will help advance our platform and our mission to protect humanity against future viral threats: https://lnkd.in/eX-Yrr47